These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
117 related articles for article (PubMed ID: 467875)
1. Drug Product Problem Reporting Program. FDA Drug Bull; 1979 Aug; 9(3):18. PubMed ID: 467875 [No Abstract] [Full Text] [Related]
2. FDA-USP drug product problem reporting program--an update. Wheatley LS Hosp Formul; 1979 Mar; 14(3):359-60, 365. PubMed ID: 10316797 [No Abstract] [Full Text] [Related]
3. Quality assurance for medical products: unified program for all federal agencies. Flaherty FJ Hosp Formul; 1976 Dec; 11(12):669, 674, 679. PubMed ID: 1028796 [No Abstract] [Full Text] [Related]
5. Pharmaceutical analysis: key to drug quality and control. Florey KG; Brewer GA Am Pharm; 1981 Aug; NS21(8):30-5. PubMed ID: 7270421 [No Abstract] [Full Text] [Related]
6. Multinational medicines--ensuring drug quality in an era of global manufacturing. Okie S N Engl J Med; 2009 Aug; 361(8):737-40. PubMed ID: 19692686 [No Abstract] [Full Text] [Related]
7. Assuring total drug quality. Simmons HE J Am Pharm Assoc; 1973 Feb; 13(2):96-8. PubMed ID: 4686621 [No Abstract] [Full Text] [Related]
8. Controlling the quality of Uncle Sam's drugs. Hecht A FDA Consum; 1977 May; 11(4):22-3. PubMed ID: 10316531 [No Abstract] [Full Text] [Related]
9. Reporting drug product defects--JCAHO. Hoffmann RP Hosp Pharm; 1989 Feb; 24(2):143-4. PubMed ID: 10318199 [No Abstract] [Full Text] [Related]
10. Assuring the quality of the nation's drugs. Interview by William E. Small. Michels D Am Pharm; 1980 Apr; NS20(4):40-2. PubMed ID: 7386377 [No Abstract] [Full Text] [Related]
11. The brand name versus generic controversy: Is there a segment of the pharmaceutical industry that produces drugs of higher quality? Marsh DA; Hoar ME Contemp Pharm Pract; 1982; 5(2):130-5. PubMed ID: 10317245 [TBL] [Abstract][Full Text] [Related]
12. [Control of drugs in foreign countries]. Buriánek J; Parrák V Cesk Farm; 1973 Jul; 22(6):247-53. PubMed ID: 4732551 [No Abstract] [Full Text] [Related]
13. Improving drug quality through certification experience. Weiss PJ Am J Pharm Sci Support Public Health; 1974; 146(3):86-90. PubMed ID: 4852375 [No Abstract] [Full Text] [Related]
14. Drug product equivalence--the problem, the challenge, and the U.S.P. Macek TJ Am J Pharm Sci Support Public Health; 1971; 143(6):188-94. PubMed ID: 5140167 [No Abstract] [Full Text] [Related]
15. Use of microbiology in drug monitoring. Kirshbaum A Bull Parenter Drug Assoc; 1971; 25(5):226-32. PubMed ID: 5109889 [No Abstract] [Full Text] [Related]
16. Securing the US pharmaceutical supply. Somberg JC Am J Ther; 2008; 15(3):197. PubMed ID: 18496255 [No Abstract] [Full Text] [Related]
19. A timely re-examination of drug polymorphism in pharmaceutical development and regulation. Grant DJ; Byrn SR Adv Drug Deliv Rev; 2004 Feb; 56(3):237-9. PubMed ID: 14962580 [No Abstract] [Full Text] [Related]